A phase II study of carboplatin in metastatic transitional cell carcinoma of the bladder (a report of the Medical Research Council Working Party on Urological Cancer, Subgroup in Advanced Bladder Cancer)
- PMID: 3301367
Item in Clipboard
A phase II study of carboplatin in metastatic transitional cell carcinoma of the bladder (a report of the Medical Research Council Working Party on Urological Cancer, Subgroup in Advanced Bladder Cancer)
Eur J Cancer Clin Oncol.
1987 Apr.
Abstract
In view of the activity of Cisplatin in bladder cancer a multicentre study of its less toxic analogue Carboplatin was carried out in 48 patients with metastatic transitional cell carcinoma, of whom 30 had received no previous cytotoxic chemotherapy. No complete remissions and only 3 partial responses were observed, suggesting that Carboplatin has only minimal activity in this disease.
Similar articles
-
[Phase II study of carboplatin in genitourinary cancer. Urological Cooperative Study Group on Carboplatin].Gan To Kagaku Ryoho. 1988 Aug;15(8):2305-11. Gan To Kagaku Ryoho. 1988. PMID: 3044277 Japanese.
-
Phase II study of carboplatin in locally advanced and metastatic transitional cell carcinoma of the urinary bladder.Br J Urol. 1989 Dec;64(6):604-7. doi: 10.1111/j.1464-410x.1989.tb05318.x. Br J Urol. 1989. PMID: 2697452
-
Retrospective analysis of satraplatin in patients with metastatic urothelial cancer refractory to standard platinum-based chemotherapy.Clin Genitourin Cancer. 2011 Sep;9(1):27-30. doi: 10.1016/j.clgc.2011.05.003. Epub 2011 Jun 22. Clin Genitourin Cancer. 2011. PMID: 21700509
-
Systemic chemotherapy in locally advanced and/or metastatic bladder cancer.Cancer Treat Rev. 2006 Oct;32(6):456-70. doi: 10.1016/j.ctrv.2006.07.004. Epub 2006 Aug 28. Cancer Treat Rev. 2006. PMID: 16935429 Review.
-
Clinical status of carboplatin.Oncology (Williston Park). 1987 Jul;1(5):61-70. Oncology (Williston Park). 1987. PMID: 3079484 Review.
Cited by
-
Carboplatin. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of cancer.Drugs. 1989 Feb;37(2):162-90. doi: 10.2165/00003495-198937020-00005. Drugs. 1989. PMID: 2649354 Review.
-
Gemcitabine and docetaxel as first-line treatment for advanced urothelial carcinoma: a phase II study.Br J Cancer. 2005 Feb 28;92(4):645-50. doi: 10.1038/sj.bjc.6602378. Br J Cancer. 2005. PMID: 15685232 Free PMC article. Clinical Trial.
-
Chemotherapy of advanced transitional-cell carcinoma of the bladder.Cancer Chemother Pharmacol. 1992;30 Suppl:S99-110. doi: 10.1007/BF00686953. Cancer Chemother Pharmacol. 1992. PMID: 1394829 Review.
-
A pharmacologically guided phase I study of carboplatin in combination with methotrexate and vinblastine in advanced urothelial cancer.Cancer Chemother Pharmacol. 1995;35(5):391-6. doi: 10.1007/s002800050252. Cancer Chemother Pharmacol. 1995. PMID: 7850920 Clinical Trial.
-
Preclinical activity of a new platinum analogue, lobaplatin, in cisplatin-sensitive and -resistant human testicular, ovarian, and gastric carcinoma cell lines.Cancer Chemother Pharmacol. 1993;33(1):43-7. doi: 10.1007/BF00686021. Cancer Chemother Pharmacol. 1993. PMID: 8269588
MeSH terms
Substances
LinkOut - more resources
Medical